BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11991509)

  • 1. Interleukin-12 administration is more effective for preventing metastasis than for inhibiting primary established tumors in a murine model of spontaneous hepatic metastasis.
    Kobayashi T; Shiiba K; Satoh M; Hashimoto W; Mizoi T; Matsuno S; Takeda K
    Surg Today; 2002; 32(3):236-42. PubMed ID: 11991509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice.
    Anzai R; Seki S; Ogasawara K; Hashimoto W; Sugiura K; Sato M; Kumagai K; Takeda K
    Immunology; 1996 May; 88(1):82-9. PubMed ID: 8707355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
    Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
    J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
    Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
    J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.
    Smyth MJ; Cretney E; Takeda K; Wiltrout RH; Sedger LM; Kayagaki N; Yagita H; Okumura K
    J Exp Med; 2001 Mar; 193(6):661-70. PubMed ID: 11257133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells.
    Shin T; Nakayama T; Akutsu Y; Motohashi S; Shibata Y; Harada M; Kamada N; Shimizu C; Shimizu E; Saito T; Ochiai T; Taniguchi M
    Int J Cancer; 2001 Feb; 91(4):523-8. PubMed ID: 11251976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.
    Siders WM; Wright PW; Hixon JA; Alvord WG; Back TC; Wiltrout RH; Fenton RG
    J Immunol; 1998 Jun; 160(11):5465-74. PubMed ID: 9605149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
    Martinet O; Ermekova V; Qiao JQ; Sauter B; Mandeli J; Chen L; Chen SH
    J Natl Cancer Inst; 2000 Jun; 92(11):931-6. PubMed ID: 10841829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma.
    Pham-Nguyen KB; Yang W; Saxena R; Thung SN; Woo SL; Chen SH
    Int J Cancer; 1999 May; 81(5):813-9. PubMed ID: 10328238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
    Kundu N; Beaty TL; Jackson MJ; Fulton AM
    J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.
    Hiraki A; Kiura K; Yamane H; Nogami N; Tabata M; Takigawa N; Ueoka H; Tanimoto M; Harada M
    Lung Cancer; 2002 Mar; 35(3):329-33. PubMed ID: 11844609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12.
    Kodama T; Takeda K; Shimozato O; Hayakawa Y; Atsuta M; Kobayashi K; Ito M; Yagita H; Okumura K
    Eur J Immunol; 1999 Apr; 29(4):1390-6. PubMed ID: 10229107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver.
    Subleski JJ; Hall VL; Back TC; Ortaldo JR; Wiltrout RH
    Cancer Res; 2006 Nov; 66(22):11005-12. PubMed ID: 17108139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases.
    Pan PY; Zang Y; Weber K; Meseck ML; Chen SH
    Mol Ther; 2002 Oct; 6(4):528-36. PubMed ID: 12377195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
    Takahashi M; Ogasawara K; Takeda K; Hashimoto W; Sakihara H; Kumagai K; Anzai R; Satoh M; Seki S
    J Immunol; 1996 Apr; 156(7):2436-42. PubMed ID: 8786302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma.
    Lo CH; Chang CM; Tang SW; Pan WY; Fang CC; Chen Y; Wu PY; Chen KY; Ma HI; Xiao X; Tao MH
    J Gene Med; 2010 May; 12(5):423-34. PubMed ID: 20440753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12.
    Hashimoto W; Takeda K; Anzai R; Ogasawara K; Sakihara H; Sugiura K; Seki S; Kumagai K
    J Immunol; 1995 May; 154(9):4333-40. PubMed ID: 7722291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.
    Takeda K; Seki S; Ogasawara K; Anzai R; Hashimoto W; Sugiura K; Takahashi M; Satoh M; Kumagai K
    J Immunol; 1996 May; 156(9):3366-73. PubMed ID: 8617962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.